IP Library Granted Patent US 12,350,422
Granted Patent B2
US 12,350,422 · App. 18/107,667 · Granted Jul 8, 2025

Machine proximate nebulizer

Inventors: Scott A. Leonard (Exeter, NH); Jesse Bodwell (Exeter, NH)
Assignee: VAPOTHERM, INC.
A61M11/04A61M11/005A61M11/02A61M11/041A61M15/0085A61M15/085A61M16/0808A61M16/14A61M2205/3334
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,350,422
App. No.
18/107,667
Granted
Jul 8, 2025
Kind
B2
Abstract

Systems and methods for providing respiratory therapy are disclosed. The system includes a nebulizer operable to aerosolize a medicament, a cylindrical mixing chamber, an impacting cap and a recirculation tube. The mixing chamber has an inlet port, an outlet port, an aerosol port in fluid communication with the nebulizer, and a drainage port. The inlet port receives a flow of breathing gas. The mixing chamber receives the aerosol via the aerosol port, entrains aerosol into the flow of breathing gas, and delivers the breathing gas entrained with aerosol to the outlet port. The impacting cap receives and coalesces a portion of the aerosol into droplets within the space defined by the mixing chamber and the impacting cap. The mixing chamber is also configured to direct rain-out resulting from the droplets to the drainage port. The system also includes a recirculation tube to return the rain-out to the nebulizer.

Claims (30)

1. A system for providing respiratory therapy to a patient comprising:

a nebulizer comprising a mesh operable to aerosolize a medicament; and

a mixing chamber having an inlet port, a cylindrical outlet port, an aerosol port in fluid communication with the nebulizer, and a drainage port,

the inlet port configured to receive a flow of breathing gas from a source of breathing gas,

the outlet port having a first end and a second end, the first end of the outlet port extending into the mixing chamber, and the second end external to the mixing chamber and configured to interfit with a delivery tube for delivery of the flow of breathing gas to the patient,

the mixing chamber configured to receive a flow of aerosol from the nebulizer via the aerosol port, entrain aerosol into the flow of breathing gas, and deliver the breathing gas entrained with aerosol to the outlet port,

the mixing chamber configured to receive the aerosol in a settling volume and cause a first portion of the aerosol to coalesce into droplets in or on any of the settling volume and an inner cylindrical wall of the mixing chamber concentric with the first end of the outlet port, the inner cylindrical wall of the mixing chamber being configured to direct rain-out resulting from the droplets toward the drainage port.

2. The system of claim 1 , wherein the drainage port is located below the inlet port, outlet port, and aerosol port.

3. The system of claim 1 , wherein the inlet port and the outlet port are in fluid communication such that the breathing gas entrained with aerosol is provided to the delivery tube via the second end of the outlet port.

4. The system of claim 1 , wherein the outlet port is arranged orthogonally to the inlet port.

5. The system of claim 1 , wherein the nebulizer comprises a reservoir containing the medicament.

6. The system of claim 5 , wherein the rain-out is stored in the nebulizer reservoir.

7. The system of claim 1 , wherein the nebulizer comprises an aerosol chamber into which the aerosol is generated.

8. The system of claim 1 , wherein the drainage port is connected to a receptacle to drain excess rain-out away from the nebulizer.

9. The system of claim 1 , wherein the mixing chamber comprises a collection compartment adjacent to the drainage port in which the rain-out collects prior to being drained by the drainage port.

10. The system of claim 1 , wherein the mesh is configured to vibrate in order to aerosolize the medicament.

11. The system of claim 10 , wherein a second portion of the aerosol coalesces into droplets on a surface of the mesh during vibration.

12. The system of claim 11 , wherein the mixing chamber comprises a conduit fluidically connecting the inlet port and the aerosol port.

13. The system of claim 12 , wherein the conduit is aligned along a direction that is normal to the surface of the mesh as the conduit fluidically connects the inlet port to the aerosol port.

14. The system of claim 13 , wherein the conduit directs the breathing gas received by the inlet port to impinge upon the surface of the mesh as it flows along the conduit to the mixing chamber.

15. The system of claim 14 , wherein the breathing gas removes the droplets from the surface of the mesh upon impingement.

16. The system of claim 1 , wherein the nebulizer is removable from the aerosol port of the mixing chamber.

17. The system of claim 16 , further comprising a removable cap configured to seal the aerosol port after removal of the nebulizer.

18. The system of claim 17 , wherein a conduit directs the flow of breathing gas to the mixing chamber and the output port for delivery to the patient after the aerosol port is sealed.

19. The system of claim 1 , wherein the medicament comprises at least one of: bronchodilators, surfactants and antibiotics.

20. The system of claim 1 , wherein the mixing chamber has a diameter that is larger than a diameter of the inlet port and a diameter of the aerosol port.

21. The system of claim 1 , comprising a recirculation tube adapted to return the rain-out to the nebulizer.

22. The system of claim 21 , wherein the recirculation tube comprises an auxiliary port for the introduction of additional medicament to the nebulizer.

23. The system of claim 21 , wherein the drainage port is coupled to a flow restrictor to control a flow rate of the recirculated rain-out.

24. The system of claim 21 , wherein a stopcock is coupled to the drainage port or the recirculation tube to enable the rain-out to be stored in a collection compartment.

Assignments (2)
SECURITY INTEREST Recorded Apr 20, 2026
From: VAPOTHERM, INC.
To: PERCEPTIVE CAPITAL SOLUTIONS HOLDINGS LP
Reel/Frame 075477/0224 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 14, 2025
From: LEONARD, SCOTT A.; BODWELL, JESSE
To: VAPOTHERM, INC.
Reel/Frame 070514/0775 →
Continuity (3)
Continuation 16428633 · May 31, 2019
Provisional Application 62678973 · May 31, 2018
Related Publication 20230285690A1 · Sep 14, 2023
References Cited (116)
US 1149010A · Olive · 1915 [cited by applicant]
US 2485184A · Seymour et al. · 1949 [cited by applicant]
US 3826255A · Havstad et al. · 1974 [cited by applicant]
US 3864326A · Babington · 1975 [cited by applicant]
US 3945378A · Paluch · 1976 [cited by applicant]
US 4028072A · Braun · 1977 [cited by examiner]
US 4177945A · Schwartz et al. · 1979 [cited by applicant]
US 4805609A · Roberts et al. · 1989 [cited by applicant]
US 4819625A · Howe · 1989 [cited by applicant]
US 4832012A · Raabe et al. · 1989 [cited by applicant]
US 4852563A · Gross · 1989 [cited by applicant]
US 4911157A · Miller · 1990 [cited by applicant]
US 4915105A · Lee · 1990 [cited by applicant]
US 4951661A · Sladek · 1990 [cited by applicant]
US 5099833A · Michaels · 1992 [cited by applicant]
US 5226411A · Levine · 1993 [cited by applicant]
US 5335656A · Bowe et al. · 1994 [cited by applicant]
US 5461695A · Knoch · 1995 [cited by applicant]
US 5584285A · Salter et al. · 1996 [cited by applicant]
US 5630409A · Bono et al. · 1997 [cited by applicant]
US 5752511A · Simmons et al. · 1998 [cited by applicant]
US 6328030B1 · Kidwell et al. · 2001 [cited by applicant]
US 6530370B1 · Heinonen · 2003 [cited by applicant]
US 6539937B1 · Haveri · 2003 [cited by applicant]
US 6769626B1 · Haveri · 2004 [cited by applicant]
US 8561607B2 · Cortez, Jr. et al. · 2013 [cited by applicant]
US 8740808B2 · Curti et al. · 2014 [cited by applicant]
US 9333317B2 · Cortez, Jr. et al. · 2016 [cited by applicant]
US 10265494B2 · Cortez, Jr. et al. · 2019 [cited by applicant]
US 10471227B1 · Morris · 2019 [cited by applicant]
US 11420002B2 · Evans et al. · 2022 [cited by applicant]
US 11439788B2 · Cortez, Jr. et al. · 2022 [cited by applicant]
US 20020053346A1 · Curti et al. · 2002 [cited by applicant]
US 20030150445A1 · Power et al. · 2003 [cited by applicant]
US 20040011364A1 · Dhuper et al. · 2004 [cited by applicant]
US 20040154617A1 · Enk · 2004 [cited by applicant]
US 20040221846A1 · Curti et al. · 2004 [cited by applicant]
US 20040237178A1 · Landeros · 2004 [cited by applicant]
US 20050217667A1 · Dhuper et al. · 2005 [cited by applicant]
US 20050229926A1 · Fink et al. · 2005 [cited by applicant]
US 20050229927A1 · Fink et al. · 2005 [cited by applicant]
US 20050229928A1 · Ivri et al. · 2005 [cited by applicant]
US 20050229929A1 · Ivri · 2005 [cited by applicant]
US 20050252509A1 · Rustad et al. · 2005 [cited by applicant]
US 20060078506A1 · Niven et al. · 2006 [cited by applicant]
US 20060120968A1 · Niven et al. · 2006 [cited by applicant]
US 20080000470A1 · Minocchieri et al. · 2008 [cited by applicant]
US 20080216841A1 · Grimes · 2008 [cited by applicant]
US 20090241948A1 · Clancy et al. · 2009 [cited by applicant]
US 20100089395A1 · Power et al. · 2010 [cited by applicant]
US 20100258114A1 · Cortez, Jr. et al. · 2010 [cited by applicant]
US 20100282247A1 · Kadrichu · 2010 [cited by examiner]
US 20110000487A1 · Moa et al. · 2011 [cited by applicant]
US 20110073116A1 · Genger et al. · 2011 [cited by applicant]
US 20110271962A1 · White et al. · 2011 [cited by applicant]
US 20130000641A1 · Mazela et al. · 2013 [cited by applicant]
US 20130074842A1 · Boucher et al. · 2013 [cited by applicant]
US 20130255670A1 · Ott et al. · 2013 [cited by applicant]
US 20130267864A1 · Addington · 2013 [cited by examiner]
US 20140109899A1 · Boucher et al. · 2014 [cited by applicant]
US 20150150803A1 · Boucher et al. · 2015 [cited by applicant]
US 20150352299A1 · Cortez, Jr. et al. · 2015 [cited by applicant]
US 20170000965A1 · Cortez, Jr. et al. · 2017 [cited by applicant]
US 20180064898A1 · Evans et al. · 2018 [cited by applicant]
US 20180272079A1 · Porter et al. · 2018 [cited by applicant]
US 20190038851A1 · Hijlkema · 2019 [cited by applicant]
US 20190366016A1 · Leonard et al. · 2019 [cited by applicant]
US 20200368483A1 · Duffy et al. · 2020 [cited by applicant]
DE 202013006445U1 · 2013 [cited by applicant]
EP 1317941A2 · 2003 [cited by applicant]
JP 2003250894A · 2003 [cited by applicant]
JP 2007537833A · 2007 [cited by applicant]
RU 2432190C2 · 2011 [cited by applicant]
WO WO1989009565A1 · 1989 [cited by applicant]
WO WO2002004054A1 · 2002 [cited by applicant]
WO WO2003035141A2 · 2003 [cited by applicant]
WO WO2005115520A1 · 2005 [cited by applicant]
WO WO2006026237A1 · 2006 [cited by applicant]
WO WO2006102345A2 · 2006 [cited by applicant]
WO WO2009078805A1 · 2009 [cited by applicant]
WO WO2009149336A2 · 2009 [cited by applicant]
WO WO2010035251A2 · 2010 [cited by applicant]
WO WO2010091259A2 · 2010 [cited by applicant]
WO WO2012020004A1 · 2012 [cited by applicant]
WO WO2012045051A1 · 2012 [cited by applicant]
WO WO2013158967A2 · 2013 [cited by applicant]
WO WO2015188179A1 · 2015 [cited by applicant]
WO WO2016157103A1 · 2016 [cited by applicant]
WO WO2017127420A1 · 2017 [cited by applicant]
WO WO2018172561A1 · 2018 [cited by applicant]
WO WO2018172562A1 · 2018 [cited by applicant]
WO WO2018172563A1 · 2018 [cited by applicant]
WO WO2019115802A1 · 2019 [cited by applicant]
U.S. Appl. No. 17/884,155, filed Aug. 9, 2022. [cited by applicant]
U.S. Appl. No. 17/560,947, filed Dec. 23, 2021. [cited by applicant]
Cairo, “Mosby's Respiratory Care Equipment,” 9th Ed. pp. 20, 98 (2014) (4 pages). [cited by applicant]
Doshi et al., “High-Velocity Nasal Insufflation in the Treatment of Respiratory Failure: A Randomized Clinical Trial”, Annals of Emergency Medicine, Jul. 2017;72(1):73-83. [cited by applicant]
International Search Report and Written Opinion for PCT/US2010/023331 dated Oct. 19, 2010 (7 pages). [cited by applicant]
International Search Report and Written Opinion for PCT/US2013/022692 dated May 23, 2013 (18 pages). [cited by applicant]
International Search Report and Written Opinion for PCT/US2015/034663 dated Aug. 20, 2015 (19 pages). [cited by applicant]
International Search Report and Written Opinion for PCT/US2019/034978 dated Dec. 11, 2019 (24 pages). [cited by applicant]
International Search Report and Written Opinion for PCT/US2019/035008 dated Sep. 9, 2019 (17 pages). [cited by applicant]
International Search Report and Written Opinion for PCT/US2021/065088 dated Jun. 14, 2022 (27 pages). [cited by applicant]
Kacmarek et al., “Egan's Fundamentals of Respiratory Care,” Physical Principles of Respiratory Care, Chap. 6, 11th Ed., pp. 123-124 (2017) (5 pages). [cited by applicant]
Sacci, R., “Air entrainment masks: Jet mixing is how they work; The Bernoulli and Venturi Principles are How They Don't”, Respiratory Care 1979, vol. 24, No. 10 (4 pages). [cited by applicant]
Spence, et al., ““Development of a High-Flow Nasal Cannula and Pharmaceutical Aerosol Combination Device””, J Aerosol Med Pulm Drug Deliv. Mar. 21, 2019. doi: 10.1089/jamp.2018.1488. [Epub ahead of print] PMID: 30855199. [cited by applicant]
Spivey S., et al., “Assessment of High Flow Nasal Cannula Therapy use in the Emergency Department Setting: Observations of Practice Across Four Systems”, Respiratory Therapy, vol. 10, No. 1, pp. 30-34 (2015). [cited by applicant]
Supplementary European Search Report for EP13740914.0 dated Jul. 8, 2015 (6 pages). [cited by applicant]
U.S. Appl. No. 13/749,162, filed Jan. 24, 2013. [cited by applicant]
U.S. Appl. No. 15/141,492, filed Apr. 28, 2016. [cited by applicant]
U.S. Appl. No. 16/293,329, filed Mar. 5, 2019. [cited by applicant]
U.S. Appl. No. 14/733,180, filed Jun. 8, 2015. [cited by applicant]
U.S. Appl. No. 16/428,473, filed May 31, 2019. [cited by applicant]
U.S. Appl. No. 16/428,633, filed May 31, 2019. [cited by applicant]
U.S. Appl. No. 18/823,238, filed Sep. 3, 2024. [cited by applicant]
U.S. Appl. No. 17/560,947, filed Dec. 21, 2021. [cited by applicant]